Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.040
+0.590 (40.55%)
Nov 7, 2024, 11:30 AM EST - Market open
Celularity Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Celularity.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Celularity.
Recommendation Trends
Rating | Aug '22 | Sep '22 | Oct '22 | Nov '22 | Dec '22 | Jan '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 1 | 1 | 1 | 1 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 3 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $50 → $10 | Hold → Sell | Downgrades | $50 → $10 | +390.20% | Jan 30, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $25 | Strong Buy | Maintains | $150 → $25 | +1,125.49% | Jan 30, 2023 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 22, 2022 |
Morgan Stanley | Morgan Stanley | Hold Maintains $80 → $50 | Hold | Maintains | $80 → $50 | +2,350.98% | Sep 12, 2022 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +7,252.94% | Aug 25, 2022 |
Financial Forecast
Revenue This Year
20.02M
from 22.77M
Decreased by -12.08%
Revenue Next Year
66.85M
from 20.02M
Increased by 233.89%
EPS This Year
-0.58
from -11.02
EPS Next Year
-0.43
from -0.58
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 20.6M | 68.8M |
Avg | 20.0M | 66.8M |
Low | 19.2M | 64.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | -9.5% | 243.7% |
Avg | -12.1% | 233.9% |
Low | -15.5% | 220.8% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.60 | -0.44 |
Avg | -0.58 | -0.43 |
Low | -0.56 | -0.41 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.